Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by Abass71on Jun 18, 2019 9:26am

98 Views

Post# 29835172

This stock is going to Zero.

Check the numbers. They have $43mill in debt and only made $207k last year in total revenue. That means they sold about 4,000 vape pens in 2018 at $50 each.
Nobody on this earth will lend them money.
I have a tiny company that I run out of my basement that made more revenue than that - with only 1 employee.
The only way to make money on this pig is to short it.
I got out at 70 cents - thank god.
GLTA

Bullboard Posts

Day trading vs. swing trading strategies for small-cap stocks